Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan
Aspirin has been used as a concomitant drug in the treatment of Kawasaki disease (KD). In recent years, there has been discussion concerning whether high-dose aspirin is appropriate for treatment in the acute phase of KD. We retrospectively investigated the incidence of coronary artery abnormalities...
Saved in:
Main Authors: | Yu Ito (Author), Takuya Matsui (Author), Kota Abe (Author), Takafumi Honda (Author), Kumi Yasukawa (Author), Jun-ichi Takanashi (Author), Hiromichi Hamada (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries
by: Junko Suzuki, et al.
Published: (2021) -
Effect of different doses of aspirin on the prognosis of Kawasaki disease
by: Jinxin Wang, et al.
Published: (2020) -
BCG and Kawasaki disease in Mexico and Japan
by: Luisa Berenise Gamez-Gonzalez, et al.
Published: (2017) -
The outcome of short-term low-dose aspirin treatment in Kawasaki disease based on inflammatory markers
by: Jae Won Yoo, et al.
Published: (2017) -
Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm
by: Farima Sanati, et al.
Published: (2021)